Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00315627 · ClinicalTrials.gov registry record · Phase 2
Steroid-free and Long-term Calcineurin-free Trial in Islet Cell Transplantation
A Phase 2 study, sponsored by Rodolfo Alejandro.
- Completed
- Registry status
- Phase 2
- Development phase
- 3
- Enrollment target
NCT00315627 is a Phase 2 study that has completed, run by Rodolfo Alejandro. The registered enrollment target is 3 participants.
The verdict
NCT00315627, a Phase 2 study, has completed, sponsored by Rodolfo Alejandro.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purposes of this study are: 1. To reverse hyperglycemia and insulin dependency in patients with type 1 diabetes mellitus through islet transplantation utilizing steroid free, calcineurin-inhibitor free immunosuppression. 2. To assess the long-term function of successful islet transplants in patients with type 1 diabetes mellitus utilizing islets that have undergone a period of culture. 3. To determine whether the natural history of the microvascular, macrovascular, and neuropathic complications are altered following the successful transplantation of islets.
Interventions
- DRUG Islet transplantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2005-07 |
| Est. Completion | 2014-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00315627
The ClinicalTrials.gov registry entry for NCT00315627 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rodolfo Alejandro, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Islet transplantation is the first listed.
NCT00315627 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00315627 about?
NCT00315627 is a clinical study titled "Steroid-free and Long-term Calcineurin-free Trial in Islet Cell Transplantation". The purposes of this study are: 1. To reverse hyperglycemia and insulin dependency in patients with type 1 diabetes mellitus through islet transplantation utilizing steroid free, calcineurin-inhibitor free immunosuppression. 2. To assess the long-term function of successful islet transplants in pat...
What is the current status of trial NCT00315627?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 3 participants. The study started on 2005-07. Estimated completion is 2014-01.
What interventions are being tested in trial NCT00315627?
The interventions under investigation include: Islet transplantation (DRUG).
Who is sponsoring clinical trial NCT00315627?
This trial is sponsored by Rodolfo Alejandro, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.